Evidence map›Paper›PMID 17874136›Full record

ArticlePediatric nephrology (Berlin, Germany)2007

Antenatal and postnatal risk factors for neonatal hypertension and infant follow-up.

Wael A Seliem, Michael C Falk, Bruce Shadbolt, Alison L Kent

Abstract read
PubMed Publisher
In one paragraph

Article in Pediatric nephrology (Berlin, Germany), 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
4.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 109 citations in OpenAlex.

  1. Article
  2. Changes in cardiorespiratory status after transcatheter patent ductus arteriosus closure.Journal of perinatology : official journal of the California Perinatal Association · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. The changing spectrum of hypertension in premature infants.Journal of perinatology : official journal of the California Perinatal Association · 2019
    Article
  16. Article
  17. Observational
  18. Neonatal hypertension: an educational review.Pediatric nephrology (Berlin, Germany) · 2019
    Review
  19. Neonatal hypertension: cases, causes, and clinical approach.Pediatric nephrology (Berlin, Germany) · 2019
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Wael A SeliemDepartment of Neonatology, The Canberra Hospital, P.O. Box 11, Woden 2606 ACT, Australia.
Michael C Falk
Bruce Shadbolt
Alison L Kent
Canberra Hospital · AUAustralian National University · AUIP Australia · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neonatal hypertension is an uncommon but important complication of intensive care management. The aims of this study were to identify in neonates with hypertension: antenatal and postnatal risk factors; aldosterone and renin levels; and report on outcome in early infancy. The study involved a retrospective review of neonates diagnosed with systemic hypertension from January 2001 to December 2005. Demographic data, risk factors, laboratory investigation, and follow-up data at 3-6 months of age were collected. Of the 2,572 newborn infants included, 34 (1.3%) had neonatal hypertension. Gestational age and birth weight and length were significantly lower in infants with hypertension. The median postnatal age at diagnosis of systemic hypertension was 5.0 days. Antenatal steroid administration, maternal hypertension, umbilical arterial catheter, postnatal acute renal failure, patent ductus arteriosus, indomethacin treatment and chronic lung disease were associated with the development of neonatal hypertension [odds ratios (OR) 8.7, 3.8, 10.0, 51.8, 5.9, 5.7 and 7.7, respectively]. Elevated aldosterone and renin levels occurred in 60% and 33% but had normalised in the majority by 6 months of age. The majority of infants do not require treatment for hypertension by 6 months of age.

Indexed as

AldosteroneAustraliaBirth WeightBlood PressureBody HeightFemaleFollow-Up StudiesGestational AgeHumansHypertensionInfantInfant, NewbornInfant, Newborn, DiseasesIntensive Care Units, NeonatalMaleOdds RatioAldosteroneRenin

Identifiers

PMID17874136
OpenAlexW2134400743

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.